Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis

被引:0
|
作者
Dubinsky, Marla C. [1 ]
Charles, Lorna [2 ]
Selmaj, Krzysztof W. [3 ,4 ]
Comi, Giancarlo [5 ,6 ]
Krakovich, Anthony [2 ]
van der Woude, C. Janneke [7 ]
Mahadevan, Uma [8 ]
机构
[1] Mt Sinai Kravis Childrens Hosp, New York, NY USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Ctr Neurol, Lodz, Poland
[4] Univ Warmia & Mazury, Coll Med, Olsztyn, Opolskie, Poland
[5] Univ Vita Salute San Raffaele, Milan, Lombardia, Italy
[6] Casa Cura Policlin, Milan, Lombardia, Italy
[7] Erasmus MC, Rotterdam, Drenthe, Netherlands
[8] Univ Calif San Francisco, San Francisco, CA USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1161
引用
收藏
页码:S887 / S887
页数:1
相关论文
共 50 条
  • [21] Review of pregnancy in Crohn's disease and ulcerative colitis
    Laube, Robyn
    Paramsothy, Sudarshan
    Leong, Rupert W.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [22] Health Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Fingolimod to Ozanimod
    Hersh, C. M.
    Paul, D.
    Wang, C.
    Poul, R.
    Khaychuk, V.
    Thorpe, A.
    Chaudhry, B.
    Reardon, J.
    Conway, D. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 198 - 199
  • [23] Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
    Karlsson, Goeril
    Francis, Gordon
    Koren, Gideon
    Heining, Peter
    Zhang, Xiaoli
    Cohen, Jeffrey A.
    Kappos, Ludwig
    Collins, William
    NEUROLOGY, 2014, 82 (08) : 674 - 680
  • [24] Pregnancy Outcomes in Women Exposed to Ustekinumab in the Crohn's Disease Clinical Development Program
    Ellen, Scherl
    Douglas, Jacobstein
    Conor, Murphy
    Elyssa, Ott
    Christopher, Gasink
    Daniel, Baumgart
    Bincy, Abraham
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S4 - S4
  • [25] Pregnancy outcomes in women exposed to ustekinumab in the Crohn's disease (CD) and ulcerative colitis (UC) clinical trials
    Abraham, Bincy
    Ott, Elyssa
    Busse, Christopher
    Murphy, Conor
    Miller, Lindsay
    Baumgart, Daniel C.
    Scherl, Ellen
    Gasink, Christopher
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 107 - 108
  • [26] Pregnancy Outcomes in Women Exposed to Ustekinumab in the Crohn's Disease Clinical Development Program
    Scherl, Ellen J.
    Jacobstein, Douglas
    Murphy, Conor
    Ott, Elyssa
    Gasink, Christopher
    Baumgart, Daniel C.
    Abraham, Bincy
    Targan, Stephan R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S332 - S333
  • [27] Development of Patient Reported Outcomes (PROs) in Ulcerative Colitis and Crohn's Disease
    Wren, Patricia A.
    Bergmans, Carrie L.
    Higgins, Peter D.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 115 - 116
  • [28] Safely through pregnancy with Crohn's disease and ulcerative colitis
    Wiestler, Miriam
    Seidler, Ursula
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (01) : 34 - 38
  • [29] Long-term Safety of Ozanimod in Patients with Moderately to Severely Active Ulcerative Colitis (UC) and Relapsing Multiple Sclerosis (RMS) Studies
    Rubin, David T.
    Wolf, Douglas C.
    Alekseeva, Olga
    Charles, Lorna
    Afsari, Sonia
    Petersen, Ann Katrin
    Sheffield, James
    Li, Hongjuan
    Silva, Diego
    Lublin, Fred D.
    Cree, Bruce
    Cohen, Jeffrey
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S396 - S396
  • [30] Clinical practice and outcomes of iron isomaltoside administration in anaemic patients with Crohn's disease and ulcerative colitis
    Stein, J.
    Hartmann, H.
    Walper, A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S404 - S405